SAN DIEGO, March 30 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) announced today that David Pendarvis, chief administrative officer, global general counsel, and secretary, plans to retire, effective June 30, 2023. He will remain in a consulting role with ResMed through December 31, 2023. ResMed will conduct an internal search for the successor to [...]
SAN DIEGO, March 13 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) announced today the results from its 2023 Global Sleep Survey in conjunction with National Sleep Awareness Week (March 12-18) and World Sleep Day (March 17) to raise awareness for the importance of sleep as a key component of physical and mental health. The [...]
SAN DIEGO, Jan. 26 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the board, effective January 25, 2023. Mr. Farrell succeeds current chair Peter Farrell who will become chair emeritus and will remain an active board member. Mick [...]
SAN DIEGO and HILDESHEIM, Germany, Nov. 22 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced it has completed its €958.6 million acquisition of MEDIFOX DAN, a German leader in software solutions for a wide variety of out-of-hospital care providers. MEDIFOX DAN is headquartered in Hildesheim, Germany, with over 700 employees. It now operates [...]
BARCELONA, Spain, Sept. 4 (Korea Bizwire) — Over 480 million people worldwide likely suffer from chronic obstructive pulmonary disease, or COPD, according to a late-breaking abstract led by ResMed (NYSE: RMD, ASX: RMD) presented at the European Respiratory Society Congress today.1 This figure is 22–126% higher than today’s most cited estimates, which range from 212–392 [...]
SAN DIEGO, June 28 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective July 1, 2022. Blaise, currently ResMed’s Vice President of Sleep & Respiratory Care for Western Europe, is a medtech industry thought leader with over 25 years’ experience in [...]
SAN DIEGO and HILDESHEIM, Germany, June 14 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, a leading software and services investor. MEDIFOX DAN’s clinical, financial, and [...]
SAN DIEGO, May 25 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Time) at the New York Hilton Midtown in New York City. More [...]
SAN FRANCISCO, May 18 (Korea Bizwire) — Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed (NYSE: RMD, ASX: RMD) and presented at the American Thoracic Society’s annual International Conference. The retrospective, observational study analyzed the [...]
SAN DIEGO, May 5 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new position and is leaving the company, effective immediately. Rob Douglas, President and Chief Operating Officer, has been appointed interim President, Sleep and Respiratory Care. [...]